Veradigm and PRA Health Sciences, Inc. announced the creation of the industry’s leading electronic healthcare records-based clinical research network that reaches more than 25,000 physicians and 40 million patients across the United States. Using Veradigm’s StudySource platform, which extends existing EHR systems to include clinical research, alongside PRA’s proprietary eSource technology and clinical research expertise, this network will enable any of physicians to offer clinical research as a care option to their patients driving efficiencies across the trial process and increasing the accessibility and diversity in clinical trials. In addition to being a burden on patients, clinical trials also can be a challenging process for trial sites and sponsors. Data management and monitoring are two of the most lengthy and costly stages of a clinical trial, yet much of this data already exists in EHR systems. With PRA’s proprietary eSource technology, data transfers can be automated from Veradigm’s EHRs to an electronic data capture system. This approach enables clients to speed drug development by decreasing the effort and time in this stage and reducing transcription errors, which provides improved data quality and reduces the need for costly source data verification.